Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

UFS gets equipment worth R3,9 million to do doping tests for the World Cup
2010-05-18

One of the new state-of-the-art machines to be used for dope testing.
Photo: Mangaliso Radebe


The South African Doping Control Laboratory (SADoCoL) at the University of the Free State (UFS) in Bloemfontein boasts new state-of-the-art equipment worth R3,9 million with which doping tests for next month’s 2010 FIFA World Cup will be done.

“Our new instruments are some of the best in the world,” said a proud Dr Pieter van der Merwe, Head of the laboratory.

SADoCoL, housed in the Department of Pharmacology at the UFS, has done doping analyses for many international sport events in South Africa and elsewhere in the world, including the 1995 Rugby World Cup and the Sevens Rugby World Cup in Dubai.

“Because of our international recognition and accreditation by the World Anti-Doping Agency (WADA) the laboratory was selected to be the official doping control facility of the 2010 FIFA World Cup,” he said.

“FIFA has entered into a contract with us and they will send all the urine and blood samples for the World Cup to this laboratory. I must hasten to say that it is not only for the World Cup. We will continue with the work that we have been doing all these years regarding doping analysis in South Africa.”

“It is an honour for the Department and the UFS to offer a world-class service to a world-class association like FIFA and to be associated with a tournament of this magnitude.”

Being the only one of its kind in South Africa, and one of only two in Africa (the other being in Tunisia), it is not surprising that FIFA has entered into this partnership with SADoCoL.

“It is a well-known fact that we have been, and still are, the official doping control testing facility in South Africa for many years now. So there is also a lot of African involvement in our laboratory where African countries send samples to us for analysis,” he said.

It is not for the first time, though, that SADoCoL is involved with FIFA. The laboratory did all the testing for the Confederations Cup that was held in South Africa in June 2009.

It had just been extended to accommodate the new equipment. An official viewing session of the new facility was held last week.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
18 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept